Experts in Non-Hodgkin Lymphoma Care
Each year at Fred Hutch Cancer Center, we care for more than 3,000 patients with non-Hodgkin lymphoma (NHL), including more than 60 rare subtypes. We provide all standard therapies. Our experts are national leaders in NHL research and have developed many of these approaches.
To make sure you get the best clinical care and research opportunities, we bring together a team of NHL experts to discuss and design your treatment. This means you benefit from the experience of the whole group.
Many of our patients take part in clinical trials — led by world-renowned physicians from Fred Hutch and UW Medicine — to get promising therapies that are not available everywhere. Through efforts like the Immunotherapy Integrated Research Center, we’re at the forefront of a fundamental shift in the way cancer is treated and cured, empowering a patient’s immune system to fight cancers like lymphoma.
Why Choose Fred Hutch for Non-Hodgkin Lymphoma Care
At Fred Hutch we combine compassionate care with innovative research to address the impact of cancer and infectious disease. We’re driven by the urgency of our patients, the hope of our community and our passion for discovery to pursue scientific breakthroughs and healthier lives for every person.